Delivery Order SPE2DB20D2001-SPE2DB24FPLKY
Award Date
9/19/24
Potential Completion Date
9/20/24
Potential Value
$6.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,594.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.25ML Moderna COVID-19 vaccines for individuals aged 6 months to 11 years, under an Emergency Use Authorization (EUA). The contract has an ultimate completion date of October 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Moderna COVID-19 vaccines for ages 6 months to 11 years old under an Emergency Use Authorization (EUA). The contract is a $4,752.75 firm fixed-price delivery order with an ultimate completion date of April 8, 2025. The contract is not a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under an Emergency Use Authorization. The $28,608.20 fixed-price delivery order contract has a completion date of July 9, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,290.00 under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 0.25ML MODERNA COVID-19 vaccines for individuals aged 6 months to 11 years, with a performance period through December 4, 2024. As an open competition contract, it does not have a set-aside designation....
This federal contract award, valued at $1,908.33, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA), with an ultimate completion date of November 12, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a $2,215.32 firm-fixed-price delivery order to supply Moderna COVID-19 vaccines for children aged 6 months to 11 years under the Emergency Use Authorization. This contract has no set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,272.22 Firm Fixed Price contract is for the delivery of Moderna COVID-19 vaccine doses (0.25mL) for ages 6 months to 11 years under the Emergency Use Authorization. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen is a for-profit...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The $1,476.88 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary supplier of pharmaceutical and medical products to the Department of Defense (DoD) and other government agencies. This...
This federal contract award, valued at $1,290.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group, under the Emergency Use Authorization (EUA). The contract has a ceiling value of $1,290.00 and an ultimate completion date of February 11, 2025. This award is part of a larger...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, has an award value of $1,272.22 and is for the delivery of 0.25 ml doses of the Moderna COVID-19 vaccine to support the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The contract is a Delivery Order under a Firm Fixed Price arrangement and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. This award is not a set-aside contract. The contract has an ultimate...